FFA
ENTA icon

Farther Finance Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Farther Finance Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53K Sell
174
-2
-1% -$27 ﹤0.01% 5088
2026
Q1 		$2.28K Buy
176
+7
+4% +$94 ﹤0.01% 4852
2025
Q4 		$2.67K Hold
169
– – ﹤0.01% 4576
2025
Q3 		$2.02K Sell
169
-5,660
-97% -$45.2K ﹤0.01% 4133
2025
Q2 		$44.1K Buy
5,829
+5,779
+11,558% +$34.8K ﹤0.01% 2195
2025
Q1 		$266 Sell
50
-8
-14% -$49 ﹤0.01% 3898
2024
Q4 		$334 Sell
58
-76
-57% -$729 ﹤0.01% 3529
2024
Q3 		$1.39K Sell
134
-4
-3% -$52 ﹤0.01% 3132
2024
Q2 		$1.8K Buy
138
+10
+8% +$135 ﹤0.01% 2836
2024
Q1 		$2.18K Sell
128
-69
-35% -$913 ﹤0.01% 2456
2023
Q4 		$1.85K Buy
197
+185
+1,542% +$1.72K ﹤0.01% 2461
2023
Q3 		$134 Buy
+12
New +$193 ﹤0.01% 2524

Other funds holding ENTA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

Farther Finance Advisors's ENTA Position: Q2 2026 in Review

Farther Finance Advisors reduced its Enanta Pharmaceuticals (ENTA) stake by 1.1% in Q2 2026, selling an estimated $27 and leaving 174 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #5088.

Farther Finance Advisors first reported a position in ENTA in Q3 2023 and has held it in 12 quarters since. The position peaked at $44.1K in Q2 2025. 10 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Farther Finance Advisors held 174 shares of Enanta Pharmaceuticals worth $2.53K as of Q2 2026.
  • Farther Finance Advisors sold 2 Enanta Pharmaceuticals shares in Q2 2026, an estimated $27.
  • Enanta Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5088 holding.
  • Farther Finance Advisors first reported a position in Enanta Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Enanta Pharmaceuticals position peaked at $44.1K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.